Prevalence, Demographics, and Treatment Characteristics of Visual Impairment due to Diabetic Macular Edema in a Representative Canadian Cohort
Diabetic macular edema (DME) is the leading cause of blindness in the diabetic population. However, there is limited understanding of the epidemiology of DME with visual impairment (VI) and treatment in patients with diabetes in Canada. This observational, retrospective study used records from the S...
Main Authors: | Robert J. Petrella, Julie Blouin, Brian Davies, Martin Barbeau |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2012/159167 |
Similar Items
-
Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian Cohort
by: Robert J. Petrella, et al.
Published: (2012-01-01) -
Ranibizumab in the treatment of patients with visual impairment due to diabetic macular edema
by: Bandello F, et al.
Published: (2011-09-01) -
Costs and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY)
by: John R. Gonder, et al.
Published: (2014-01-01) -
Demographic, medical and visual aspects of diabetic retinopathy and diabetic macular edema
by: Sukha, Anusha Yasvantrai
Published: (2014) -
Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India
by: Unnikrishnan Nair, et al.
Published: (2020-10-01)